MIR6768

Across TCGA pan-cancer cohorts, MIR6768 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR6768 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR6768 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6768 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

MESO, KIRC, and UVM are the cancer types where MIR6768 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.232	0.435	<.001	156	view →
KIRC	DFS	Tertile	All	0.405	0.650	<.001	126	view →
UVM	OS	Tertile	II,III,IV	0.412	0.739	.001	117	view →
UCEC	DFS	Median	All	0.844	0.923	<.001	116	view →
ACC	OS	Tertile	All	0.641	0.917	<.001	91	view →
KIRP	OS	Tertile	All	0.830	0.948	<.001	84	view →
HNSC	OS	Tertile	II,III,IV	0.818	0.523	.001	36	view →
PRAD	DFS	Tertile	All	0.853	0.945	.001	30	view →
LUAD	DFS	Tertile	IV	0.723	0.414	.020	18	view →
ESCA	DFS	Tertile	All	1.000	0.524	.010	15	view →
TGCT	DFS	Quartile	All	0.914	0.670	.012	12	view →
COAD	DFS	Tertile	III,IV	0.426	0.595	.028	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR6768–MESO (OS)

Open the MESO breakdown →